As of February 2026, Eli Lilly & Co. had a forecast five-year average growth of over ** percent from 2026 to 2030, the highest among the leading pharmaceutical companies globally. Regeneron Pharmaceuticals followed with an average growth of about percent during the same period.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
S&P Global. (March 3, 2026). Estimated average growth of major pharmaceutical companies from 2026 to 2030 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 21, 2026, from /statistics/1660236/major-pharmaceutical-companies-growth/
S&P Global. "Estimated average growth of major pharmaceutical companies from 2026 to 2030." Chart. March 3, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 21, 2026. /statistics/1660236/major-pharmaceutical-companies-growth/
S&P Global. (2026). Estimated average growth of major pharmaceutical companies from 2026 to 2030. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 21, 2026. /statistics/1660236/major-pharmaceutical-companies-growth/
S&P Global. "Estimated Average Growth of Major Pharmaceutical Companies from 2026 to 2030." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 3 Mar 2026, /statistics/1660236/major-pharmaceutical-companies-growth/
S&P Global, Estimated average growth of major pharmaceutical companies from 2026 to 2030 ÌÇÐÄÆƽâ°æ, /statistics/1660236/major-pharmaceutical-companies-growth/ (last visited July 21, 2026)
Estimated average growth of major pharmaceutical companies from 2026 to 2030 [Graph], S&P Global, March 3, 2026. [Online]. Available: /statistics/1660236/major-pharmaceutical-companies-growth/
